Suppr超能文献

2型糖尿病患者十年糖化血红蛋白轨迹与结局:糖尿病与衰老研究

Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study.

作者信息

Laiteerapong Neda, Karter Andrew J, Moffet Howard H, Cooper Jennifer M, Gibbons Robert D, Liu Jennifer Y, Gao Yue, Huang Elbert S

机构信息

Section of General Internal Medicine, Department of Medicine, University of Chicago, 5841 S Maryland Avenue, MC 2007, Chicago, IL 60637, USA.

Division of Research, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612, USA.

出版信息

J Diabetes Complications. 2017 Jan;31(1):94-100. doi: 10.1016/j.jdiacomp.2016.07.023. Epub 2016 Jul 26.

Abstract

AIMS

To classify trajectories of long term HbA1c values in patients after diagnosis of type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality.

METHODS

A longitudinal follow-up of 28,016 patients newly diagnosed with type 2 diabetes was conducted. Latent growth mixture modeling was used to identify ten-year HbA1c trajectories. Cox proportional hazards models were used to assess how HbA1c trajectories were associated with events (microvascular and macrovascular) and mortality.

RESULTS

We identified 5 HbA1c trajectories: "low stable" (82.5%), "moderate increasing late" (5.1%), "high decreasing early" (4.9%), "moderate peaking late" (4.1%) and "moderate peaking early" (3.3%). After adjusting for average HbA1c, compared to the low stable trajectory, all non-stable trajectories were associated with higher incidences of microvascular events (hazard ratio (HR) range, 1.28 (95% CI, 1.08-1.53) (high decreasing early) to 1.45 (95% CI, 1.20-1.75) (moderate peaking early)). The high decreasing early trajectory was associated with an increased mortality risk (HR, 1.27 (95% CI, 1.03-1.58)). Trajectories were not associated with macrovascular events.

CONCLUSIONS

Non-stable HbA1c trajectories were associated with greater risk of microvascular events and mortality. These findings suggest a potential benefit of early diabetes detection, prioritizing good glycemic control, and maintaining control over time.

摘要

目的

对2型糖尿病患者确诊后的长期糖化血红蛋白(HbA1c)值轨迹进行分类,并研究各轨迹与随后微血管和大血管事件及死亡率的关联。

方法

对28016例新诊断的2型糖尿病患者进行纵向随访。采用潜在增长混合模型识别十年HbA1c轨迹。使用Cox比例风险模型评估HbA1c轨迹与事件(微血管和大血管)及死亡率的关联。

结果

我们识别出5种HbA1c轨迹:“低稳定型”(82.5%)、“中度晚期上升型”(5.1%)、“高度早期下降型”(4.9%)、“中度晚期峰值型”(4.1%)和“中度早期峰值型”(3.3%)。在调整平均HbA1c后,与低稳定轨迹相比,所有非稳定轨迹均与微血管事件的较高发生率相关(风险比(HR)范围为1.28(95%置信区间,1.08 - 1.53)(高度早期下降型)至1.45(95%置信区间,1.20 - 1.75)(中度早期峰值型))。高度早期下降型轨迹与死亡风险增加相关(HR,1.27(95%置信区间,1.03 - 1.58))。轨迹与大血管事件无关。

结论

非稳定的HbA1c轨迹与微血管事件和死亡的更高风险相关。这些发现提示早期糖尿病检测、优先实现良好血糖控制以及长期维持控制可能具有潜在益处。

相似文献

1
Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study.
J Diabetes Complications. 2017 Jan;31(1):94-100. doi: 10.1016/j.jdiacomp.2016.07.023. Epub 2016 Jul 26.
4
Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes.
Nephrology (Carlton). 2019 Oct;24(10):1026-1032. doi: 10.1111/nep.13533. Epub 2019 May 2.
5
Effect of Hemoglobin A1c Trajectories on Future Outcomes in a 10-Year Cohort With Type 2 Diabetes Mellitus.
Front Endocrinol (Lausanne). 2022 Apr 5;13:846823. doi: 10.3389/fendo.2022.846823. eCollection 2022.
7
Trajectories of hemoglobin A1c and body mass index z-score over four decades among 2 to 18 year olds with type 1 diabetes.
Pediatr Diabetes. 2019 Aug;20(5):594-603. doi: 10.1111/pedi.12862. Epub 2019 May 14.
8
Association Between Baseline Glycemic Markers (HbA1c) and 8-Year Trajectories of Functional Disability.
J Gerontol A Biol Sci Med Sci. 2019 Oct 4;74(11):1828-1834. doi: 10.1093/gerona/glz089.

引用本文的文献

2
Association between estimated glucose disposal rate and major adverse cardiovascular events in patients with type 2 diabetes.
PLoS One. 2025 Jul 17;20(7):e0328252. doi: 10.1371/journal.pone.0328252. eCollection 2025.
4
Modeling recurrent heart failure risk in type 2 diabetes: impact of flexible HbA1c trajectories using nonhomogeneous Poisson processes.
Front Endocrinol (Lausanne). 2025 Apr 21;16:1472846. doi: 10.3389/fendo.2025.1472846. eCollection 2025.
5
The role of glycemic traits in the mediation of the causal effect of hypothyroidism on coronary heart disease.
Front Endocrinol (Lausanne). 2024 Sep 30;15:1436713. doi: 10.3389/fendo.2024.1436713. eCollection 2024.
6
TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort.
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3065-3075. doi: 10.1210/clinem/dgae294.
7
Longitudinal trajectories of glycemic control among U.S. Adults with newly diagnosed diabetes.
Diabetes Res Clin Pract. 2023 Nov;205:110989. doi: 10.1016/j.diabres.2023.110989. Epub 2023 Nov 2.
9
Measuring continuity of care for diabetes: which visits to include?
Am J Manag Care. 2023 Sep 1;29(9):e274-e279. doi: 10.37765/ajmc.2023.89431.
10
Association of hemoglobin A1c stability with mortality and diabetes complications in older adults with diabetes.
BMJ Open Diabetes Res Care. 2023 Apr;11(2). doi: 10.1136/bmjdrc-2022-003211.

本文引用的文献

3
Association between HbA1c variability and mortality in patients with type 2 diabetes.
J Diabetes Complications. 2014 Jul-Aug;28(4):494-9. doi: 10.1016/j.jdiacomp.2014.02.006. Epub 2014 Feb 18.
5
Standards of medical care in diabetes--2014.
Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014.
6
The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.
N Engl J Med. 2013 Oct 3;369(14):1285-7. doi: 10.1056/NEJMp1309610. Epub 2013 Sep 2.
7
Glycemic variability: both sides of the story.
Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S272-5. doi: 10.2337/dcS13-2030.
10
HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
Diabetologia. 2012 Dec;55(12):3163-72. doi: 10.1007/s00125-012-2700-4. Epub 2012 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验